Deep Brain Stimulation in Parkinson\'s Disease Market
Deep Brain Stimulation in Parkinson\'s Disease
Market Scope: Industry Analysis, Market Size,
Growth, Trends Till 2031
Request Sample Report
Deep Brain Stimulation in Parkinson\'s Disease Market
Size and Growth
The Deep Brain Stimulation (DBS) market for Parkinson's Disease is expanding rapidly, valued at approximately $1.5 billion in 2023. Key market drivers include rising prevalence of Parkinson’s, technological advancements, and increasing awareness of DBS benefits. Competitive dynamics and evolving patient demographics are shaping market opportunities and growth trajectories in the coming years.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott
◍ Aleva Neurotherapeutics SA
◍ Beijing PINS Medical Co
◍ Boston Scientific Corporation
◍ Functional Neuromodulation Ltd
◍ Medtronic
◍ Neuronetics Inc.
◍ NeuroPace Inc.
◍ Nevro Corporation
The Deep Brain Stimulation market for Parkinson's disease features key players like Abbott, Medtronic, and Boston Scientific, offering innovative devices to enhance patient outcomes. Companies drive market growth through R&D, strategic partnerships, and improved therapies. Sales revenue from Medtronic topped $30 billion, while Boston Scientific reached approximately $10 billion. Request Sample Report
Market Segmentation
By Application
Hospitals ◍ Neurology Clinics ◍ Research Centers
By Product
◍ Dual Channel Deep brain Stimulator
Single Channel Deep brain Stimulator
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
